Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Notch signal strength controls cell fate in the haemogenic endothelium.

  • Gama-Norton, Leonor
  • Ferrando Martorell, Eva, 1986-
  • Ruiz Herguido, Cristina
  • Liu, Zenhy
  • Guiu Sagarra, Jordi, 1983-
  • Islam, Abul, 1978-
  • Lee, Sung-Uk
  • Yan, Minhong
  • Guidos, Cynthia J.
  • López Bigas, Núria
  • Maeda, Takahiro
  • Espinosa Blay, Lluís
  • Kopan, Raphael
  • Bigas Salvans, Anna
Acquisition of the arterial and haemogenic endothelium fates concurrently occur in the aorta-gonad-mesonephros (AGM) region prior to haematopoietic stem cell (HSC) generation. The arterial programme depends on Dll4 and the haemogenic endothelium/HSC on Jag1-mediated Notch1 signalling. How Notch1 distinguishes and executes these different programmes in response to particular ligands is poorly understood. By using two Notch1 activation trap mouse models with different sensitivity, here we show that arterial endothelial cells and HSCs originate from distinct precursors, characterized by different Notch1 signal strengths. Microarray analysis on AGM subpopulations demonstrates that the Jag1 ligand stimulates low Notch strength, inhibits the endothelial programme and is permissive for HSC specification. In the absence of Jag1, endothelial cells experience high Dll4-induced Notch activity and select the endothelial programme, thus precluding HSC formation. Interference with the Dll4 signal by ligand-specific blocking antibodies is sufficient to inhibit the endothelial programme and favour specification of the haematopoietic lineage., L.G.-N. was a recipient of Marie Curie Intra-European Fellowship (PIEF-GA-2011- 302226). E.F. and J.G. are recipients of FPI (BES-2011-048360 and BES-2008-005708, respectively). This research was funded by the Ministerio de Economıa y Competitividad (PLE2009-0111, SAF2010-15450, SAF2013-40922-R), Red Tematica de Investigacion Cooperativa en Cancer (RTICC) (RD12/0036/0054), Age`ncia de Gestio d’Ajuds Universitaris i de Recerca (AGAUR; 2014SGR-124) to A.B.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Identification of Cdca7 as a novel Notch transcriptional target involved in hematopoietic stem cell emergence

  • Islam, Abul, 1978-
  • Guiu Sagarra, Jordi, 1983-
  • Bergen, Dylan J.M.
  • de Pater, Emma
  • Ayllon, Verónica
  • Gama-Norton, Leonor
  • Ruiz Herguido, Cristina
  • González, Jessica
  • López Bigas, Núria
  • Menéndez, Pablo
  • Dzierzak, Elaine
  • Espinosa Blay, Lluís
  • Bigas Salvans, Anna
Hematopoietic stem cell (HSC) specification occurs in the embryonic aorta and requires Notch activation; however, most of the Notch-regulated elements controlling de novo HSC generation are still unknown. Here, we identify putative direct Notch targets in the aorta-gonad-mesonephros (AGM) embryonic tissue by chromatin precipitation using antibodies against the Notch partner RBPj. By ChIP-on-chip analysis of the precipitated DNA, we identified 701 promoter regions that were candidates to be regulated by Notch in the AGM. One of the most enriched regions corresponded to the Cdca7 gene, which was subsequently confirmed to recruit the RBPj factor but also Notch1 in AGM cells. We found that during embryonic hematopoietic development, expression of Cdca7 is restricted to the hematopoietic clusters of the aorta, and it is strongly up-regulated in the hemogenic population during human embryonic stem cell hematopoietic differentiation in a Notch-dependent manner. Down-regulation of Cdca7 mRNA in cultured AGM cells significantly induces hematopoietic differentiation and loss of the progenitor population. Finally, using loss-of-function experiments in zebrafish, we demonstrate that CDCA7 contributes to HSC emergence in vivo during embryonic development. Thus, our study identifies Cdca7 as an evolutionary conserved Notch target involved in HSC emergence., J. Guiu was a recipient of Formación Personal Investigador (FPI) BES-2008-005708. This research was funded by grants from the Ministerio de Economía y Competitividad, FEDER (SAF2007-60080, PLE2009-0111, SAF2010-15450, and SAF2013-40922R), Red Temática de Investigación Cooperativa en Cáncer (RTICC; RD06/0020/0098 and RD12/0036/0054), Association for International Cancer Research (AICR; 13-0064), Agència de Gestió d’Ajuds Universitaris i de Recerca (AGAUR; 2009SGR-23, CONES2010-0006) to A. Bigas, the Spanish Association against Cancer Research (AECC) to A. Bigas and P. Menendez, Fondo de Investigación Sanitaria (FIS; PI10/00449) to P. Menendez, and ZonMW TOP (40-00812-98-11068) to E. Dzierzak and E. De Pater.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Notch signal strength controls cell fate in the haemogenic endothelium.

  • Gama-Norton, Leonor
  • Ferrando Martorell, Eva, 1986-
  • Ruiz Herguido, Cristina
  • Liu, Zenhy
  • Guiu Sagarra, Jordi, 1983-
  • Islam, Abul, 1978-
  • Lee, Sung-Uk
  • Yan, Minhong
  • Guidos, Cynthia J.
  • López Bigas, Núria
  • Maeda, Takahiro
  • Espinosa Blay, Lluís
  • Kopan, Raphael
  • Bigas Salvans, Anna
Acquisition of the arterial and haemogenic endothelium fates concurrently occur in the aorta-gonad-mesonephros (AGM) region prior to haematopoietic stem cell (HSC) generation. The arterial programme depends on Dll4 and the haemogenic endothelium/HSC on Jag1-mediated Notch1 signalling. How Notch1 distinguishes and executes these different programmes in response to particular ligands is poorly understood. By using two Notch1 activation trap mouse models with different sensitivity, here we show that arterial endothelial cells and HSCs originate from distinct precursors, characterized by different Notch1 signal strengths. Microarray analysis on AGM subpopulations demonstrates that the Jag1 ligand stimulates low Notch strength, inhibits the endothelial programme and is permissive for HSC specification. In the absence of Jag1, endothelial cells experience high Dll4-induced Notch activity and select the endothelial programme, thus precluding HSC formation. Interference with the Dll4 signal by ligand-specific blocking antibodies is sufficient to inhibit the endothelial programme and favour specification of the haematopoietic lineage., L.G.-N. was a recipient of Marie Curie Intra-European Fellowship (PIEF-GA-2011- 302226). E.F. and J.G. are recipients of FPI (BES-2011-048360 and BES-2008-005708, respectively). This research was funded by the Ministerio de Economıa y Competitividad (PLE2009-0111, SAF2010-15450, SAF2013-40922-R), Red Tematica de Investigacion Cooperativa en Cancer (RTICC) (RD12/0036/0054), Age`ncia de Gestio d’Ajuds Universitaris i de Recerca (AGAUR; 2014SGR-124) to A.B.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Identification of Cdca7 as a novel Notch transcriptional target involved in hematopoietic stem cell emergence

  • Islam, Abul, 1978-
  • Guiu Sagarra, Jordi, 1983-
  • Bergen, Dylan J.M.
  • de Pater, Emma
  • Ayllon, Verónica
  • Gama-Norton, Leonor
  • Ruiz Herguido, Cristina
  • González, Jessica
  • López Bigas, Núria
  • Menéndez, Pablo
  • Dzierzak, Elaine
  • Espinosa Blay, Lluís
  • Bigas Salvans, Anna
Hematopoietic stem cell (HSC) specification occurs in the embryonic aorta and requires Notch activation; however, most of the Notch-regulated elements controlling de novo HSC generation are still unknown. Here, we identify putative direct Notch targets in the aorta-gonad-mesonephros (AGM) embryonic tissue by chromatin precipitation using antibodies against the Notch partner RBPj. By ChIP-on-chip analysis of the precipitated DNA, we identified 701 promoter regions that were candidates to be regulated by Notch in the AGM. One of the most enriched regions corresponded to the Cdca7 gene, which was subsequently confirmed to recruit the RBPj factor but also Notch1 in AGM cells. We found that during embryonic hematopoietic development, expression of Cdca7 is restricted to the hematopoietic clusters of the aorta, and it is strongly up-regulated in the hemogenic population during human embryonic stem cell hematopoietic differentiation in a Notch-dependent manner. Down-regulation of Cdca7 mRNA in cultured AGM cells significantly induces hematopoietic differentiation and loss of the progenitor population. Finally, using loss-of-function experiments in zebrafish, we demonstrate that CDCA7 contributes to HSC emergence in vivo during embryonic development. Thus, our study identifies Cdca7 as an evolutionary conserved Notch target involved in HSC emergence., J. Guiu was a recipient of Formación Personal Investigador (FPI) BES-2008-005708. This research was funded by grants from the Ministerio de Economía y Competitividad, FEDER (SAF2007-60080, PLE2009-0111, SAF2010-15450, and SAF2013-40922R), Red Temática de Investigación Cooperativa en Cáncer (RTICC; RD06/0020/0098 and RD12/0036/0054), Association for International Cancer Research (AICR; 13-0064), Agència de Gestió d’Ajuds Universitaris i de Recerca (AGAUR; 2009SGR-23, CONES2010-0006) to A. Bigas, the Spanish Association against Cancer Research (AECC) to A. Bigas and P. Menendez, Fondo de Investigación Sanitaria (FIS; PI10/00449) to P. Menendez, and ZonMW TOP (40-00812-98-11068) to E. Dzierzak and E. De Pater.